amitriptyline and interleukin-8

amitriptyline has been researched along with interleukin-8 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berton, G; Bezzerri, V; Cabrini, G; Cioffi, F; Dechecchi, MC; Gambari, R; Huang, S; Lampronti, I; Mazzi, P; Nicolis, E; Scupoli, MT; Wiszniewski, L	1
Albertoni Giraldes, AL; Brunialti, MK; Leal, PD; Sakata, RK; Salomão, R	1

Trials

1 trial(s) available for amitriptyline and interleukin-8

Article	Year
Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study. International journal of rheumatic diseases, 2016, Volume: 19, Issue:10 Topics: Administration, Intravenous; Adult; Amitriptyline; Anesthetics, Local; Biomarkers; Brazil; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Lidocaine; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome	2016

Article

Year

Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study.

International journal of rheumatic diseases, 2016, Volume: 19, Issue:10

Topics: Administration, Intravenous; Adult; Amitriptyline; Anesthetics, Local; Biomarkers; Brazil; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Lidocaine; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome

2016

Other Studies

1 other study(ies) available for amitriptyline and interleukin-8

Article	Year
Modulators of sphingolipid metabolism reduce lung inflammation. American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:4 Topics: 1-Deoxynojirimycin; Amitriptyline; Animals; Anti-Inflammatory Agents; Cell Line; Ceramides; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunity, Innate; Inflammation Mediators; Interleukin-8; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Pneumonia; Pseudomonas aeruginosa; Respiratory Mucosa	2011

Article

Year

Modulators of sphingolipid metabolism reduce lung inflammation.

American journal of respiratory cell and molecular biology, 2011, Volume: 45, Issue:4

Topics: 1-Deoxynojirimycin; Amitriptyline; Animals; Anti-Inflammatory Agents; Cell Line; Ceramides; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunity, Innate; Inflammation Mediators; Interleukin-8; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Pneumonia; Pseudomonas aeruginosa; Respiratory Mucosa

2011